nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP2C8—Nicotine—ulcerative colitis	0.076	0.153	CbGbCtD
Trametinib—CYP3A4—Budesonide—ulcerative colitis	0.0708	0.142	CbGbCtD
Trametinib—CYP2C8—Cholecalciferol—ulcerative colitis	0.0681	0.137	CbGbCtD
Trametinib—CYP2C8—Hydrocortisone—ulcerative colitis	0.0474	0.0954	CbGbCtD
Trametinib—CYP3A4—Methylprednisolone—ulcerative colitis	0.0316	0.0636	CbGbCtD
Trametinib—CYP3A4—Nicotine—ulcerative colitis	0.0308	0.062	CbGbCtD
Trametinib—CYP2C8—Dexamethasone—ulcerative colitis	0.0295	0.0593	CbGbCtD
Trametinib—CYP3A4—Cholecalciferol—ulcerative colitis	0.0276	0.0556	CbGbCtD
Trametinib—CYP3A4—Triamcinolone—ulcerative colitis	0.024	0.0482	CbGbCtD
Trametinib—CYP3A4—Betamethasone—ulcerative colitis	0.0206	0.0414	CbGbCtD
Trametinib—CYP3A4—Prednisolone—ulcerative colitis	0.0203	0.0408	CbGbCtD
Trametinib—CYP3A4—Hydrocortisone—ulcerative colitis	0.0192	0.0387	CbGbCtD
Trametinib—CYP3A4—Prednisone—ulcerative colitis	0.0192	0.0385	CbGbCtD
Trametinib—CYP3A4—Dexamethasone—ulcerative colitis	0.012	0.0241	CbGbCtD
Trametinib—MAP2K1—epithelium—ulcerative colitis	0.00408	0.139	CbGeAlD
Trametinib—MAP2K1—smooth muscle tissue—ulcerative colitis	0.00393	0.134	CbGeAlD
Trametinib—MAP2K2—smooth muscle tissue—ulcerative colitis	0.00346	0.118	CbGeAlD
Trametinib—MAP2K1—lymphoid tissue—ulcerative colitis	0.00314	0.107	CbGeAlD
Trametinib—MAP2K1—digestive system—ulcerative colitis	0.00311	0.106	CbGeAlD
Trametinib—MAP2K2—lymphoid tissue—ulcerative colitis	0.00277	0.0941	CbGeAlD
Trametinib—MAP2K2—digestive system—ulcerative colitis	0.00273	0.093	CbGeAlD
Trametinib—MAP2K1—liver—ulcerative colitis	0.00231	0.0787	CbGeAlD
Trametinib—MAP2K2—liver—ulcerative colitis	0.00204	0.0693	CbGeAlD
Trametinib—CYP2C8—liver—ulcerative colitis	0.000705	0.024	CbGeAlD
Trametinib—CYP3A4—digestive system—ulcerative colitis	0.000641	0.0218	CbGeAlD
Trametinib—CYP3A4—liver—ulcerative colitis	0.000478	0.0163	CbGeAlD
Trametinib—Abdominal pain—Budesonide—ulcerative colitis	0.000277	0.00127	CcSEcCtD
Trametinib—Body temperature increased—Budesonide—ulcerative colitis	0.000277	0.00127	CcSEcCtD
Trametinib—Skin disorder—Mesalazine—ulcerative colitis	0.000276	0.00127	CcSEcCtD
Trametinib—Hyperhidrosis—Mesalazine—ulcerative colitis	0.000275	0.00127	CcSEcCtD
Trametinib—Hyperglycaemia—Dexamethasone—ulcerative colitis	0.000274	0.00126	CcSEcCtD
Trametinib—Hyperglycaemia—Betamethasone—ulcerative colitis	0.000274	0.00126	CcSEcCtD
Trametinib—Bradycardia—Triamcinolone—ulcerative colitis	0.000273	0.00126	CcSEcCtD
Trametinib—Bradycardia—Methylprednisolone—ulcerative colitis	0.000272	0.00125	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.00027	0.00124	CcSEcCtD
Trametinib—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.00027	0.00124	CcSEcCtD
Trametinib—Haemoglobin—Triamcinolone—ulcerative colitis	0.00027	0.00124	CcSEcCtD
Trametinib—Haemoglobin—Methylprednisolone—ulcerative colitis	0.000269	0.00124	CcSEcCtD
Trametinib—Haemorrhage—Triamcinolone—ulcerative colitis	0.000268	0.00124	CcSEcCtD
Trametinib—Haemorrhage—Methylprednisolone—ulcerative colitis	0.000268	0.00123	CcSEcCtD
Trametinib—Eye disorder—Hydrocortisone—ulcerative colitis	0.000266	0.00123	CcSEcCtD
Trametinib—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000263	0.00121	CcSEcCtD
Trametinib—Arrhythmia—Prednisolone—ulcerative colitis	0.000261	0.0012	CcSEcCtD
Trametinib—Pancreatitis—Prednisone—ulcerative colitis	0.00026	0.0012	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000259	0.00119	CcSEcCtD
Trametinib—Insomnia—Mesalazine—ulcerative colitis	0.000257	0.00119	CcSEcCtD
Trametinib—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000255	0.00118	CcSEcCtD
Trametinib—Arrhythmia—Hydrocortisone—ulcerative colitis	0.000254	0.00117	CcSEcCtD
Trametinib—Erythema—Prednisolone—ulcerative colitis	0.000254	0.00117	CcSEcCtD
Trametinib—Asthenia—Budesonide—ulcerative colitis	0.000251	0.00116	CcSEcCtD
Trametinib—Eye disorder—Methylprednisolone—ulcerative colitis	0.00025	0.00115	CcSEcCtD
Trametinib—Mental disorder—Hydrocortisone—ulcerative colitis	0.00025	0.00115	CcSEcCtD
Trametinib—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000248	0.00114	CcSEcCtD
Trametinib—Malnutrition—Hydrocortisone—ulcerative colitis	0.000248	0.00114	CcSEcCtD
Trametinib—Erythema—Hydrocortisone—ulcerative colitis	0.000248	0.00114	CcSEcCtD
Trametinib—Bradycardia—Betamethasone—ulcerative colitis	0.000248	0.00114	CcSEcCtD
Trametinib—Bradycardia—Dexamethasone—ulcerative colitis	0.000248	0.00114	CcSEcCtD
Trametinib—Neutropenia—Prednisone—ulcerative colitis	0.000248	0.00114	CcSEcCtD
Trametinib—Pruritus—Budesonide—ulcerative colitis	0.000248	0.00114	CcSEcCtD
Trametinib—Decreased appetite—Mesalazine—ulcerative colitis	0.000247	0.00114	CcSEcCtD
Trametinib—Abdominal pain—Azathioprine—ulcerative colitis	0.000247	0.00114	CcSEcCtD
Trametinib—Body temperature increased—Azathioprine—ulcerative colitis	0.000247	0.00114	CcSEcCtD
Trametinib—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000246	0.00113	CcSEcCtD
Trametinib—Fatigue—Mesalazine—ulcerative colitis	0.000245	0.00113	CcSEcCtD
Trametinib—Haemoglobin—Dexamethasone—ulcerative colitis	0.000245	0.00113	CcSEcCtD
Trametinib—Haemoglobin—Betamethasone—ulcerative colitis	0.000245	0.00113	CcSEcCtD
Trametinib—Constipation—Mesalazine—ulcerative colitis	0.000243	0.00112	CcSEcCtD
Trametinib—Haemorrhage—Dexamethasone—ulcerative colitis	0.000243	0.00112	CcSEcCtD
Trametinib—Haemorrhage—Betamethasone—ulcerative colitis	0.000243	0.00112	CcSEcCtD
Trametinib—Angiopathy—Methylprednisolone—ulcerative colitis	0.000243	0.00112	CcSEcCtD
Trametinib—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000241	0.00111	CcSEcCtD
Trametinib—Arrhythmia—Triamcinolone—ulcerative colitis	0.00024	0.0011	CcSEcCtD
Trametinib—Diarrhoea—Budesonide—ulcerative colitis	0.000239	0.0011	CcSEcCtD
Trametinib—Vision blurred—Prednisolone—ulcerative colitis	0.000239	0.0011	CcSEcCtD
Trametinib—Arrhythmia—Methylprednisolone—ulcerative colitis	0.000239	0.0011	CcSEcCtD
Trametinib—Hyperglycaemia—Prednisone—ulcerative colitis	0.000239	0.0011	CcSEcCtD
Trametinib—Mental disorder—Methylprednisolone—ulcerative colitis	0.000234	0.00108	CcSEcCtD
Trametinib—Erythema—Triamcinolone—ulcerative colitis	0.000233	0.00108	CcSEcCtD
Trametinib—Malnutrition—Methylprednisolone—ulcerative colitis	0.000233	0.00107	CcSEcCtD
Trametinib—Erythema—Methylprednisolone—ulcerative colitis	0.000233	0.00107	CcSEcCtD
Trametinib—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000233	0.00107	CcSEcCtD
Trametinib—Dizziness—Budesonide—ulcerative colitis	0.000231	0.00107	CcSEcCtD
Trametinib—Dysgeusia—Triamcinolone—ulcerative colitis	0.000229	0.00105	CcSEcCtD
Trametinib—Eye disorder—Betamethasone—ulcerative colitis	0.000227	0.00105	CcSEcCtD
Trametinib—Eye disorder—Dexamethasone—ulcerative colitis	0.000227	0.00105	CcSEcCtD
Trametinib—Back pain—Triamcinolone—ulcerative colitis	0.000226	0.00104	CcSEcCtD
Trametinib—Abdominal pain—Mesalazine—ulcerative colitis	0.000225	0.00104	CcSEcCtD
Trametinib—Body temperature increased—Mesalazine—ulcerative colitis	0.000225	0.00104	CcSEcCtD
Trametinib—Vomiting—Budesonide—ulcerative colitis	0.000222	0.00102	CcSEcCtD
Trametinib—Angiopathy—Betamethasone—ulcerative colitis	0.000221	0.00102	CcSEcCtD
Trametinib—Angiopathy—Dexamethasone—ulcerative colitis	0.000221	0.00102	CcSEcCtD
Trametinib—Rash—Budesonide—ulcerative colitis	0.000221	0.00102	CcSEcCtD
Trametinib—Dermatitis—Budesonide—ulcerative colitis	0.00022	0.00102	CcSEcCtD
Trametinib—Headache—Budesonide—ulcerative colitis	0.000219	0.00101	CcSEcCtD
Trametinib—Hypertension—Prednisolone—ulcerative colitis	0.000219	0.00101	CcSEcCtD
Trametinib—Arrhythmia—Dexamethasone—ulcerative colitis	0.000217	0.001	CcSEcCtD
Trametinib—Arrhythmia—Betamethasone—ulcerative colitis	0.000217	0.001	CcSEcCtD
Trametinib—Bradycardia—Prednisone—ulcerative colitis	0.000216	0.000994	CcSEcCtD
Trametinib—Hypertension—Hydrocortisone—ulcerative colitis	0.000214	0.000986	CcSEcCtD
Trametinib—Diarrhoea—Azathioprine—ulcerative colitis	0.000214	0.000985	CcSEcCtD
Trametinib—Haemoglobin—Prednisone—ulcerative colitis	0.000213	0.000981	CcSEcCtD
Trametinib—Haemorrhage—Prednisone—ulcerative colitis	0.000212	0.000976	CcSEcCtD
Trametinib—Erythema—Betamethasone—ulcerative colitis	0.000212	0.000976	CcSEcCtD
Trametinib—Erythema—Dexamethasone—ulcerative colitis	0.000212	0.000976	CcSEcCtD
Trametinib—Myalgia—Hydrocortisone—ulcerative colitis	0.000211	0.000972	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.00021	0.000966	CcSEcCtD
Trametinib—Connective tissue disorder—Prednisone—ulcerative colitis	0.000208	0.000959	CcSEcCtD
Trametinib—Nausea—Budesonide—ulcerative colitis	0.000208	0.000957	CcSEcCtD
Trametinib—Oedema—Prednisolone—ulcerative colitis	0.000207	0.000954	CcSEcCtD
Trametinib—Dizziness—Azathioprine—ulcerative colitis	0.000207	0.000952	CcSEcCtD
Trametinib—Asthenia—Mesalazine—ulcerative colitis	0.000204	0.00094	CcSEcCtD
Trametinib—Cough—Triamcinolone—ulcerative colitis	0.000204	0.000938	CcSEcCtD
Trametinib—Oedema—Hydrocortisone—ulcerative colitis	0.000202	0.000932	CcSEcCtD
Trametinib—Hypertension—Triamcinolone—ulcerative colitis	0.000202	0.000928	CcSEcCtD
Trametinib—Pruritus—Mesalazine—ulcerative colitis	0.000201	0.000927	CcSEcCtD
Trametinib—Hypertension—Methylprednisolone—ulcerative colitis	0.000201	0.000926	CcSEcCtD
Trametinib—Infection—Hydrocortisone—ulcerative colitis	0.000201	0.000926	CcSEcCtD
Trametinib—Hyperhidrosis—Prednisolone—ulcerative colitis	0.0002	0.000923	CcSEcCtD
Trametinib—Myalgia—Triamcinolone—ulcerative colitis	0.000199	0.000916	CcSEcCtD
Trametinib—Vomiting—Azathioprine—ulcerative colitis	0.000199	0.000915	CcSEcCtD
Trametinib—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000198	0.000914	CcSEcCtD
Trametinib—Myalgia—Methylprednisolone—ulcerative colitis	0.000198	0.000914	CcSEcCtD
Trametinib—Arthralgia—Methylprednisolone—ulcerative colitis	0.000198	0.000914	CcSEcCtD
Trametinib—Eye disorder—Prednisone—ulcerative colitis	0.000198	0.000912	CcSEcCtD
Trametinib—Rash—Azathioprine—ulcerative colitis	0.000197	0.000907	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000197	0.000907	CcSEcCtD
Trametinib—Dermatitis—Azathioprine—ulcerative colitis	0.000197	0.000907	CcSEcCtD
Trametinib—Skin disorder—Hydrocortisone—ulcerative colitis	0.000197	0.000905	CcSEcCtD
Trametinib—Headache—Azathioprine—ulcerative colitis	0.000196	0.000902	CcSEcCtD
Trametinib—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000196	0.000901	CcSEcCtD
Trametinib—Diarrhoea—Mesalazine—ulcerative colitis	0.000195	0.000897	CcSEcCtD
Trametinib—Dry mouth—Triamcinolone—ulcerative colitis	0.000194	0.000895	CcSEcCtD
Trametinib—Angiopathy—Prednisone—ulcerative colitis	0.000192	0.000886	CcSEcCtD
Trametinib—Oedema—Triamcinolone—ulcerative colitis	0.000191	0.000878	CcSEcCtD
Trametinib—Arrhythmia—Prednisone—ulcerative colitis	0.000189	0.000872	CcSEcCtD
Trametinib—Infection—Triamcinolone—ulcerative colitis	0.000189	0.000872	CcSEcCtD
Trametinib—Infection—Methylprednisolone—ulcerative colitis	0.000189	0.00087	CcSEcCtD
Trametinib—Dizziness—Mesalazine—ulcerative colitis	0.000188	0.000867	CcSEcCtD
Trametinib—Insomnia—Prednisolone—ulcerative colitis	0.000187	0.000863	CcSEcCtD
Trametinib—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000186	0.000859	CcSEcCtD
Trametinib—Mental disorder—Prednisone—ulcerative colitis	0.000186	0.000855	CcSEcCtD
Trametinib—Nausea—Azathioprine—ulcerative colitis	0.000186	0.000855	CcSEcCtD
Trametinib—Skin disorder—Methylprednisolone—ulcerative colitis	0.000185	0.000851	CcSEcCtD
Trametinib—Erythema—Prednisone—ulcerative colitis	0.000184	0.00085	CcSEcCtD
Trametinib—Malnutrition—Prednisone—ulcerative colitis	0.000184	0.00085	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000184	0.000849	CcSEcCtD
Trametinib—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000184	0.000848	CcSEcCtD
Trametinib—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000184	0.000847	CcSEcCtD
Trametinib—Insomnia—Hydrocortisone—ulcerative colitis	0.000183	0.000843	CcSEcCtD
Trametinib—Hypertension—Betamethasone—ulcerative colitis	0.000183	0.000842	CcSEcCtD
Trametinib—Hypertension—Dexamethasone—ulcerative colitis	0.000183	0.000842	CcSEcCtD
Trametinib—Vomiting—Mesalazine—ulcerative colitis	0.000181	0.000833	CcSEcCtD
Trametinib—Myalgia—Dexamethasone—ulcerative colitis	0.00018	0.000831	CcSEcCtD
Trametinib—Myalgia—Betamethasone—ulcerative colitis	0.00018	0.000831	CcSEcCtD
Trametinib—Rash—Mesalazine—ulcerative colitis	0.000179	0.000826	CcSEcCtD
Trametinib—Dermatitis—Mesalazine—ulcerative colitis	0.000179	0.000826	CcSEcCtD
Trametinib—Headache—Mesalazine—ulcerative colitis	0.000178	0.000821	CcSEcCtD
Trametinib—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000176	0.00081	CcSEcCtD
Trametinib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000175	0.000805	CcSEcCtD
Trametinib—Fatigue—Hydrocortisone—ulcerative colitis	0.000174	0.000804	CcSEcCtD
Trametinib—Vision blurred—Prednisone—ulcerative colitis	0.000174	0.000801	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000174	0.0008	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000173	0.000798	CcSEcCtD
Trametinib—Oedema—Dexamethasone—ulcerative colitis	0.000173	0.000796	CcSEcCtD
Trametinib—Oedema—Betamethasone—ulcerative colitis	0.000173	0.000796	CcSEcCtD
Trametinib—Insomnia—Triamcinolone—ulcerative colitis	0.000172	0.000794	CcSEcCtD
Trametinib—Insomnia—Methylprednisolone—ulcerative colitis	0.000172	0.000792	CcSEcCtD
Trametinib—Infection—Dexamethasone—ulcerative colitis	0.000172	0.000791	CcSEcCtD
Trametinib—Infection—Betamethasone—ulcerative colitis	0.000172	0.000791	CcSEcCtD
Trametinib—Anaemia—Prednisone—ulcerative colitis	0.000171	0.000785	CcSEcCtD
Trametinib—Nervous system disorder—Dexamethasone—ulcerative colitis	0.00017	0.000781	CcSEcCtD
Trametinib—Nervous system disorder—Betamethasone—ulcerative colitis	0.00017	0.000781	CcSEcCtD
Trametinib—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000169	0.00078	CcSEcCtD
Trametinib—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000169	0.00078	CcSEcCtD
Trametinib—Nausea—Mesalazine—ulcerative colitis	0.000169	0.000779	CcSEcCtD
Trametinib—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000167	0.00077	CcSEcCtD
Trametinib—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000167	0.00077	CcSEcCtD
Trametinib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000165	0.000762	CcSEcCtD
Trametinib—Fatigue—Triamcinolone—ulcerative colitis	0.000164	0.000757	CcSEcCtD
Trametinib—Fatigue—Methylprednisolone—ulcerative colitis	0.000164	0.000755	CcSEcCtD
Trametinib—Abdominal pain—Hydrocortisone—ulcerative colitis	0.00016	0.000737	CcSEcCtD
Trametinib—Body temperature increased—Hydrocortisone—ulcerative colitis	0.00016	0.000737	CcSEcCtD
Trametinib—Hypertension—Prednisone—ulcerative colitis	0.000159	0.000734	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000158	0.000726	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000158	0.000726	CcSEcCtD
Trametinib—Arthralgia—Prednisone—ulcerative colitis	0.000157	0.000723	CcSEcCtD
Trametinib—Myalgia—Prednisone—ulcerative colitis	0.000157	0.000723	CcSEcCtD
Trametinib—Insomnia—Dexamethasone—ulcerative colitis	0.000156	0.00072	CcSEcCtD
Trametinib—Insomnia—Betamethasone—ulcerative colitis	0.000156	0.00072	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000156	0.000718	CcSEcCtD
Trametinib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000155	0.000716	CcSEcCtD
Trametinib—Body temperature increased—Triamcinolone—ulcerative colitis	0.000151	0.000694	CcSEcCtD
Trametinib—Oedema—Prednisone—ulcerative colitis	0.000151	0.000694	CcSEcCtD
Trametinib—Abdominal pain—Methylprednisolone—ulcerative colitis	0.00015	0.000692	CcSEcCtD
Trametinib—Decreased appetite—Dexamethasone—ulcerative colitis	0.00015	0.000692	CcSEcCtD
Trametinib—Decreased appetite—Betamethasone—ulcerative colitis	0.00015	0.000692	CcSEcCtD
Trametinib—Infection—Prednisone—ulcerative colitis	0.00015	0.000689	CcSEcCtD
Trametinib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000149	0.000688	CcSEcCtD
Trametinib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000149	0.000688	CcSEcCtD
Trametinib—Fatigue—Dexamethasone—ulcerative colitis	0.000149	0.000687	CcSEcCtD
Trametinib—Fatigue—Betamethasone—ulcerative colitis	0.000149	0.000687	CcSEcCtD
Trametinib—Nervous system disorder—Prednisone—ulcerative colitis	0.000148	0.00068	CcSEcCtD
Trametinib—Skin disorder—Prednisone—ulcerative colitis	0.000146	0.000674	CcSEcCtD
Trametinib—Hyperhidrosis—Prednisone—ulcerative colitis	0.000146	0.00067	CcSEcCtD
Trametinib—Asthenia—Hydrocortisone—ulcerative colitis	0.000145	0.000669	CcSEcCtD
Trametinib—Pruritus—Hydrocortisone—ulcerative colitis	0.000143	0.000659	CcSEcCtD
Trametinib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000141	0.000651	CcSEcCtD
Trametinib—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000141	0.000651	CcSEcCtD
Trametinib—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000138	0.000638	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000137	0.000632	CcSEcCtD
Trametinib—Dizziness—Prednisolone—ulcerative colitis	0.000137	0.000631	CcSEcCtD
Trametinib—Asthenia—Triamcinolone—ulcerative colitis	0.000137	0.00063	CcSEcCtD
Trametinib—Body temperature increased—Dexamethasone—ulcerative colitis	0.000137	0.00063	CcSEcCtD
Trametinib—Body temperature increased—Betamethasone—ulcerative colitis	0.000137	0.00063	CcSEcCtD
Trametinib—Abdominal pain—Betamethasone—ulcerative colitis	0.000137	0.00063	CcSEcCtD
Trametinib—Abdominal pain—Dexamethasone—ulcerative colitis	0.000137	0.00063	CcSEcCtD
Trametinib—Asthenia—Methylprednisolone—ulcerative colitis	0.000136	0.000628	CcSEcCtD
Trametinib—Insomnia—Prednisone—ulcerative colitis	0.000136	0.000627	CcSEcCtD
Trametinib—Pruritus—Triamcinolone—ulcerative colitis	0.000135	0.000621	CcSEcCtD
Trametinib—Pruritus—Methylprednisolone—ulcerative colitis	0.000135	0.00062	CcSEcCtD
Trametinib—Dizziness—Hydrocortisone—ulcerative colitis	0.000134	0.000616	CcSEcCtD
Trametinib—Decreased appetite—Prednisone—ulcerative colitis	0.000131	0.000603	CcSEcCtD
Trametinib—Rash—Prednisolone—ulcerative colitis	0.000131	0.000602	CcSEcCtD
Trametinib—Dermatitis—Prednisolone—ulcerative colitis	0.000131	0.000601	CcSEcCtD
Trametinib—Diarrhoea—Methylprednisolone—ulcerative colitis	0.00013	0.000599	CcSEcCtD
Trametinib—Fatigue—Prednisone—ulcerative colitis	0.00013	0.000598	CcSEcCtD
Trametinib—Headache—Prednisolone—ulcerative colitis	0.00013	0.000598	CcSEcCtD
Trametinib—Constipation—Prednisone—ulcerative colitis	0.000129	0.000593	CcSEcCtD
Trametinib—Vomiting—Hydrocortisone—ulcerative colitis	0.000129	0.000593	CcSEcCtD
Trametinib—Rash—Hydrocortisone—ulcerative colitis	0.000128	0.000588	CcSEcCtD
Trametinib—Dermatitis—Hydrocortisone—ulcerative colitis	0.000127	0.000587	CcSEcCtD
Trametinib—Headache—Hydrocortisone—ulcerative colitis	0.000127	0.000584	CcSEcCtD
Trametinib—Dizziness—Triamcinolone—ulcerative colitis	0.000126	0.00058	CcSEcCtD
Trametinib—Dizziness—Methylprednisolone—ulcerative colitis	0.000126	0.000579	CcSEcCtD
Trametinib—Asthenia—Betamethasone—ulcerative colitis	0.000124	0.000571	CcSEcCtD
Trametinib—Asthenia—Dexamethasone—ulcerative colitis	0.000124	0.000571	CcSEcCtD
Trametinib—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000123	0.000567	CcSEcCtD
Trametinib—Nausea—Prednisolone—ulcerative colitis	0.000123	0.000567	CcSEcCtD
Trametinib—Pruritus—Betamethasone—ulcerative colitis	0.000122	0.000563	CcSEcCtD
Trametinib—Pruritus—Dexamethasone—ulcerative colitis	0.000122	0.000563	CcSEcCtD
Trametinib—Vomiting—Triamcinolone—ulcerative colitis	0.000121	0.000558	CcSEcCtD
Trametinib—Vomiting—Methylprednisolone—ulcerative colitis	0.000121	0.000557	CcSEcCtD
Trametinib—Nausea—Hydrocortisone—ulcerative colitis	0.00012	0.000554	CcSEcCtD
Trametinib—Rash—Triamcinolone—ulcerative colitis	0.00012	0.000553	CcSEcCtD
Trametinib—Dermatitis—Triamcinolone—ulcerative colitis	0.00012	0.000553	CcSEcCtD
Trametinib—Rash—Methylprednisolone—ulcerative colitis	0.00012	0.000552	CcSEcCtD
Trametinib—Dermatitis—Methylprednisolone—ulcerative colitis	0.00012	0.000552	CcSEcCtD
Trametinib—Headache—Triamcinolone—ulcerative colitis	0.000119	0.00055	CcSEcCtD
Trametinib—Headache—Methylprednisolone—ulcerative colitis	0.000119	0.000549	CcSEcCtD
Trametinib—Abdominal pain—Prednisone—ulcerative colitis	0.000119	0.000548	CcSEcCtD
Trametinib—Body temperature increased—Prednisone—ulcerative colitis	0.000119	0.000548	CcSEcCtD
Trametinib—Diarrhoea—Dexamethasone—ulcerative colitis	0.000118	0.000545	CcSEcCtD
Trametinib—Diarrhoea—Betamethasone—ulcerative colitis	0.000118	0.000545	CcSEcCtD
Trametinib—Dizziness—Betamethasone—ulcerative colitis	0.000114	0.000527	CcSEcCtD
Trametinib—Dizziness—Dexamethasone—ulcerative colitis	0.000114	0.000527	CcSEcCtD
Trametinib—Nausea—Triamcinolone—ulcerative colitis	0.000113	0.000521	CcSEcCtD
Trametinib—Nausea—Methylprednisolone—ulcerative colitis	0.000113	0.00052	CcSEcCtD
Trametinib—Vomiting—Betamethasone—ulcerative colitis	0.00011	0.000506	CcSEcCtD
Trametinib—Vomiting—Dexamethasone—ulcerative colitis	0.00011	0.000506	CcSEcCtD
Trametinib—Rash—Dexamethasone—ulcerative colitis	0.000109	0.000502	CcSEcCtD
Trametinib—Rash—Betamethasone—ulcerative colitis	0.000109	0.000502	CcSEcCtD
Trametinib—Dermatitis—Dexamethasone—ulcerative colitis	0.000109	0.000502	CcSEcCtD
Trametinib—Dermatitis—Betamethasone—ulcerative colitis	0.000109	0.000502	CcSEcCtD
Trametinib—Headache—Betamethasone—ulcerative colitis	0.000108	0.000499	CcSEcCtD
Trametinib—Headache—Dexamethasone—ulcerative colitis	0.000108	0.000499	CcSEcCtD
Trametinib—Asthenia—Prednisone—ulcerative colitis	0.000108	0.000498	CcSEcCtD
Trametinib—Pruritus—Prednisone—ulcerative colitis	0.000107	0.000491	CcSEcCtD
Trametinib—Diarrhoea—Prednisone—ulcerative colitis	0.000103	0.000475	CcSEcCtD
Trametinib—Nausea—Betamethasone—ulcerative colitis	0.000103	0.000473	CcSEcCtD
Trametinib—Nausea—Dexamethasone—ulcerative colitis	0.000103	0.000473	CcSEcCtD
Trametinib—Dizziness—Prednisone—ulcerative colitis	9.96e-05	0.000459	CcSEcCtD
Trametinib—Vomiting—Prednisone—ulcerative colitis	9.57e-05	0.000441	CcSEcCtD
Trametinib—Rash—Prednisone—ulcerative colitis	9.49e-05	0.000437	CcSEcCtD
Trametinib—Dermatitis—Prednisone—ulcerative colitis	9.49e-05	0.000437	CcSEcCtD
Trametinib—Headache—Prednisone—ulcerative colitis	9.43e-05	0.000434	CcSEcCtD
Trametinib—Nausea—Prednisone—ulcerative colitis	8.94e-05	0.000412	CcSEcCtD
Trametinib—MAP2K2—Signaling by GPCR—PTGER4—ulcerative colitis	6.88e-05	0.000268	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—RELA—ulcerative colitis	6.88e-05	0.000268	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—JAK2—ulcerative colitis	6.87e-05	0.000268	CbGpPWpGaD
Trametinib—MAP2K2—Toll-Like Receptors Cascades—IL6—ulcerative colitis	6.85e-05	0.000267	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—IL6—ulcerative colitis	6.85e-05	0.000267	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FCGR2A—ulcerative colitis	6.81e-05	0.000266	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—STAT3—ulcerative colitis	6.78e-05	0.000264	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL1B—ulcerative colitis	6.76e-05	0.000264	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL2—ulcerative colitis	6.73e-05	0.000263	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IRF8—ulcerative colitis	6.68e-05	0.000261	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CCR6—ulcerative colitis	6.68e-05	0.000261	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	6.67e-05	0.00026	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—IL6—ulcerative colitis	6.56e-05	0.000256	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PTPN2—ulcerative colitis	6.53e-05	0.000255	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SLC11A1—ulcerative colitis	6.51e-05	0.000254	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TP53—ulcerative colitis	6.51e-05	0.000254	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—ADCY5—ulcerative colitis	6.5e-05	0.000253	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—IL6—ulcerative colitis	6.48e-05	0.000253	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—IL6—ulcerative colitis	6.45e-05	0.000252	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PTGER4—ulcerative colitis	6.44e-05	0.000251	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—JAK2—ulcerative colitis	6.43e-05	0.000251	CbGpPWpGaD
Trametinib—MAP2K1—Toll-Like Receptors Cascades—IL6—ulcerative colitis	6.41e-05	0.00025	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—IL6—ulcerative colitis	6.41e-05	0.00025	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FCGR2A—ulcerative colitis	6.37e-05	0.000249	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL1B—ulcerative colitis	6.32e-05	0.000247	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—NFKB1—ulcerative colitis	6.31e-05	0.000246	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—GHRL—ulcerative colitis	6.3e-05	0.000246	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL2—ulcerative colitis	6.3e-05	0.000246	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CXCR1—ulcerative colitis	6.28e-05	0.000245	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MAML2—ulcerative colitis	6.25e-05	0.000244	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	6.23e-05	0.000243	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—NFKB1—ulcerative colitis	6.2e-05	0.000242	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—IL6—ulcerative colitis	6.16e-05	0.00024	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—IL6—ulcerative colitis	6.13e-05	0.000239	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—IL6—ulcerative colitis	6.13e-05	0.000239	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PTPN2—ulcerative colitis	6.11e-05	0.000238	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CALM3—ulcerative colitis	6.1e-05	0.000238	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—IL6—ulcerative colitis	6.1e-05	0.000238	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TP53—ulcerative colitis	6.09e-05	0.000237	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CRP—ulcerative colitis	6.08e-05	0.000237	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—IL6—ulcerative colitis	6.07e-05	0.000237	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—IL6—ulcerative colitis	6.04e-05	0.000235	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—NFKB1—ulcerative colitis	5.9e-05	0.00023	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—GHRL—ulcerative colitis	5.89e-05	0.00023	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CXCR1—ulcerative colitis	5.87e-05	0.000229	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—PPARG—ulcerative colitis	5.86e-05	0.000229	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MAML2—ulcerative colitis	5.85e-05	0.000228	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—TLR4—ulcerative colitis	5.82e-05	0.000227	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—NFKB1—ulcerative colitis	5.8e-05	0.000226	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—IL6—ulcerative colitis	5.76e-05	0.000225	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—IL6—ulcerative colitis	5.74e-05	0.000224	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—IL6—ulcerative colitis	5.71e-05	0.000223	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—IL6—ulcerative colitis	5.71e-05	0.000223	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—IL6—ulcerative colitis	5.71e-05	0.000223	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CALM3—ulcerative colitis	5.71e-05	0.000223	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—IL6—ulcerative colitis	5.71e-05	0.000223	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CRP—ulcerative colitis	5.68e-05	0.000222	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—IL6—ulcerative colitis	5.68e-05	0.000221	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—MMP9—ulcerative colitis	5.67e-05	0.000221	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—STAT3—ulcerative colitis	5.67e-05	0.000221	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—IL6—ulcerative colitis	5.66e-05	0.000221	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—IL6—ulcerative colitis	5.61e-05	0.000219	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—IL6—ulcerative colitis	5.59e-05	0.000218	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CALM3—ulcerative colitis	5.57e-05	0.000217	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—STAT3—ulcerative colitis	5.57e-05	0.000217	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL20—ulcerative colitis	5.51e-05	0.000215	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	5.49e-05	0.000214	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—RIPK2—ulcerative colitis	5.49e-05	0.000214	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—PPARG—ulcerative colitis	5.49e-05	0.000214	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—TLR4—ulcerative colitis	5.45e-05	0.000212	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CTLA4—ulcerative colitis	5.41e-05	0.000211	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CHP1—ulcerative colitis	5.4e-05	0.000211	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—IL6—ulcerative colitis	5.34e-05	0.000208	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—IL6—ulcerative colitis	5.34e-05	0.000208	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—IL6—ulcerative colitis	5.34e-05	0.000208	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—MMP9—ulcerative colitis	5.31e-05	0.000207	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—STAT3—ulcerative colitis	5.3e-05	0.000207	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—IL6—ulcerative colitis	5.3e-05	0.000207	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—IL6—ulcerative colitis	5.25e-05	0.000205	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—IL6—ulcerative colitis	5.23e-05	0.000204	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CALM3—ulcerative colitis	5.22e-05	0.000203	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—ADRB2—ulcerative colitis	5.21e-05	0.000203	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—STAT3—ulcerative colitis	5.21e-05	0.000203	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GNA12—ulcerative colitis	5.18e-05	0.000202	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD79A—ulcerative colitis	5.16e-05	0.000201	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL20—ulcerative colitis	5.15e-05	0.000201	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CALM3—ulcerative colitis	5.15e-05	0.000201	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—RIPK2—ulcerative colitis	5.14e-05	0.0002	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CTLA4—ulcerative colitis	5.06e-05	0.000197	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5.06e-05	0.000197	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	5.06e-05	0.000197	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—NOD2—ulcerative colitis	4.98e-05	0.000194	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD14—ulcerative colitis	4.95e-05	0.000193	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CXCR2—ulcerative colitis	4.91e-05	0.000191	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—JAK2—ulcerative colitis	4.9e-05	0.000191	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	4.89e-05	0.000191	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—ADRB2—ulcerative colitis	4.88e-05	0.00019	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GNA12—ulcerative colitis	4.85e-05	0.000189	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD79A—ulcerative colitis	4.83e-05	0.000188	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CALM3—ulcerative colitis	4.82e-05	0.000188	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—VCAM1—ulcerative colitis	4.78e-05	0.000186	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-DQA1—ulcerative colitis	4.76e-05	0.000186	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—RELA—ulcerative colitis	4.75e-05	0.000185	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	4.73e-05	0.000185	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—DLD—ulcerative colitis	4.66e-05	0.000182	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—NOD2—ulcerative colitis	4.66e-05	0.000182	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD14—ulcerative colitis	4.63e-05	0.000181	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCR6—ulcerative colitis	4.62e-05	0.00018	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CXCR2—ulcerative colitis	4.59e-05	0.000179	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—JAK2—ulcerative colitis	4.59e-05	0.000179	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	4.57e-05	0.000178	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—VCAM1—ulcerative colitis	4.47e-05	0.000174	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-DQA1—ulcerative colitis	4.46e-05	0.000174	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—RELA—ulcerative colitis	4.44e-05	0.000173	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—ADCY5—ulcerative colitis	4.43e-05	0.000173	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAML2—ulcerative colitis	4.38e-05	0.000171	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—JAK2—ulcerative colitis	4.33e-05	0.000169	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCR6—ulcerative colitis	4.32e-05	0.000168	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—RELA—ulcerative colitis	4.19e-05	0.000163	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—ADCY5—ulcerative colitis	4.14e-05	0.000161	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CD4—ulcerative colitis	4.1e-05	0.00016	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAML2—ulcerative colitis	4.09e-05	0.00016	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PTGER4—ulcerative colitis	4.06e-05	0.000158	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—JAK2—ulcerative colitis	4.05e-05	0.000158	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—MMP9—ulcerative colitis	4.05e-05	0.000158	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ADCY5—ulcerative colitis	4.04e-05	0.000158	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—NFKB1—ulcerative colitis	4e-05	0.000156	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL6—ulcerative colitis	3.96e-05	0.000154	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—RELA—ulcerative colitis	3.92e-05	0.000153	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—IL6—ulcerative colitis	3.89e-05	0.000152	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CD4—ulcerative colitis	3.84e-05	0.00015	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PTGER4—ulcerative colitis	3.8e-05	0.000148	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—MMP9—ulcerative colitis	3.79e-05	0.000148	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ADCY5—ulcerative colitis	3.78e-05	0.000148	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—NFKB1—ulcerative colitis	3.75e-05	0.000146	CbGpPWpGaD
Trametinib—MAP2K2—Disease—ADCY5—ulcerative colitis	3.73e-05	0.000146	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GHRL—ulcerative colitis	3.72e-05	0.000145	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL6—ulcerative colitis	3.7e-05	0.000144	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—IL6—ulcerative colitis	3.64e-05	0.000142	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CALM3—ulcerative colitis	3.6e-05	0.000141	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—STAT3—ulcerative colitis	3.6e-05	0.00014	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RIPK2—ulcerative colitis	3.55e-05	0.000138	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CRP—ulcerative colitis	3.54e-05	0.000138	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—NFKB1—ulcerative colitis	3.54e-05	0.000138	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—IL6—ulcerative colitis	3.52e-05	0.000137	CbGpPWpGaD
Trametinib—MAP2K1—Disease—ADCY5—ulcerative colitis	3.49e-05	0.000136	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GHRL—ulcerative colitis	3.48e-05	0.000136	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—TLR4—ulcerative colitis	3.39e-05	0.000132	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-DRB1—ulcerative colitis	3.39e-05	0.000132	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CALM3—ulcerative colitis	3.37e-05	0.000131	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—STAT3—ulcerative colitis	3.37e-05	0.000131	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TGFB1—ulcerative colitis	3.33e-05	0.00013	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RIPK2—ulcerative colitis	3.32e-05	0.00013	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CRP—ulcerative colitis	3.31e-05	0.000129	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—NFKB1—ulcerative colitis	3.31e-05	0.000129	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—IL6—ulcerative colitis	3.29e-05	0.000128	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ICAM1—ulcerative colitis	3.25e-05	0.000127	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—TLR4—ulcerative colitis	3.17e-05	0.000124	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-DRB1—ulcerative colitis	3.17e-05	0.000124	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TGFB1—ulcerative colitis	3.12e-05	0.000122	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TNF—ulcerative colitis	3.11e-05	0.000121	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ADRB2—ulcerative colitis	3.08e-05	0.00012	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ICAM1—ulcerative colitis	3.04e-05	0.000119	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TNF—ulcerative colitis	2.91e-05	0.000114	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CHP1—ulcerative colitis	2.9e-05	0.000113	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ADRB2—ulcerative colitis	2.88e-05	0.000112	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CDH1—ulcerative colitis	2.88e-05	0.000112	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—JAK2—ulcerative colitis	2.76e-05	0.000108	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CDH1—ulcerative colitis	2.69e-05	0.000105	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ADCY5—ulcerative colitis	2.61e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—JAK2—ulcerative colitis	2.58e-05	0.000101	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—JAK2—ulcerative colitis	2.52e-05	9.83e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CXCL8—ulcerative colitis	2.52e-05	9.82e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—IL6—ulcerative colitis	2.51e-05	9.8e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DLD—ulcerative colitis	2.5e-05	9.76e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IFNG—ulcerative colitis	2.47e-05	9.65e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.47e-05	9.61e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ADCY5—ulcerative colitis	2.45e-05	9.54e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—RELA—ulcerative colitis	2.44e-05	9.52e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL2—ulcerative colitis	2.41e-05	9.38e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD4—ulcerative colitis	2.39e-05	9.32e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—JAK2—ulcerative colitis	2.36e-05	9.2e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CXCL8—ulcerative colitis	2.36e-05	9.19e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—IL6—ulcerative colitis	2.35e-05	9.17e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—JAK2—ulcerative colitis	2.33e-05	9.08e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IFNG—ulcerative colitis	2.32e-05	9.03e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—RELA—ulcerative colitis	2.28e-05	8.91e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS1—ulcerative colitis	2.25e-05	8.79e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL2—ulcerative colitis	2.25e-05	8.78e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD4—ulcerative colitis	2.24e-05	8.72e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IL6—ulcerative colitis	2.22e-05	8.65e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.22e-05	8.64e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL1B—ulcerative colitis	2.21e-05	8.61e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CD4—ulcerative colitis	2.21e-05	8.6e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL2—ulcerative colitis	2.2e-05	8.57e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTGS2—ulcerative colitis	2.19e-05	8.54e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—JAK2—ulcerative colitis	2.18e-05	8.49e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—ulcerative colitis	2.08e-05	8.1e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1B—ulcerative colitis	2.07e-05	8.05e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CD4—ulcerative colitis	2.06e-05	8.05e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—NFKB1—ulcerative colitis	2.06e-05	8.03e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL2—ulcerative colitis	2.06e-05	8.02e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTGS2—ulcerative colitis	2.05e-05	7.99e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CALM3—ulcerative colitis	2.03e-05	7.91e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.94e-05	7.56e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—NFKB1—ulcerative colitis	1.93e-05	7.51e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—STAT3—ulcerative colitis	1.85e-05	7.22e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—STAT3—ulcerative colitis	1.73e-05	6.75e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—STAT3—ulcerative colitis	1.71e-05	6.66e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—JAK2—ulcerative colitis	1.63e-05	6.36e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—STAT3—ulcerative colitis	1.6e-05	6.23e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TGFB1—ulcerative colitis	1.58e-05	6.18e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RELA—ulcerative colitis	1.58e-05	6.16e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ABCB1—ulcerative colitis	1.58e-05	6.15e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—JAK2—ulcerative colitis	1.53e-05	5.95e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CXCL8—ulcerative colitis	1.49e-05	5.8e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TGFB1—ulcerative colitis	1.48e-05	5.78e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RELA—ulcerative colitis	1.48e-05	5.76e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ADCY5—ulcerative colitis	1.47e-05	5.74e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL2—ulcerative colitis	1.42e-05	5.54e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—ulcerative colitis	1.41e-05	5.52e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CXCL8—ulcerative colitis	1.39e-05	5.43e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MMP9—ulcerative colitis	1.35e-05	5.25e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NFKB1—ulcerative colitis	1.33e-05	5.19e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL2—ulcerative colitis	1.33e-05	5.19e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—ulcerative colitis	1.32e-05	5.16e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—ulcerative colitis	1.29e-05	5.04e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MMP9—ulcerative colitis	1.26e-05	4.91e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NFKB1—ulcerative colitis	1.25e-05	4.86e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.21e-05	4.72e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—ulcerative colitis	1.21e-05	4.72e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—STAT3—ulcerative colitis	1.2e-05	4.67e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—ulcerative colitis	1.19e-05	4.65e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—STAT3—ulcerative colitis	1.12e-05	4.36e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—ulcerative colitis	1.12e-05	4.35e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TGFB1—ulcerative colitis	1.11e-05	4.32e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARG—ulcerative colitis	1.1e-05	4.28e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.09e-05	4.25e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TGFB1—ulcerative colitis	1.04e-05	4.05e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALB—ulcerative colitis	9.87e-06	3.85e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TP53—ulcerative colitis	9.13e-06	3.56e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS2—ulcerative colitis	8.64e-06	3.37e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TP53—ulcerative colitis	8.54e-06	3.33e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	8.47e-06	3.3e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—ulcerative colitis	8.36e-06	3.26e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	7.9e-06	3.08e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—ulcerative colitis	7.82e-06	3.05e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARG—ulcerative colitis	5.89e-06	2.3e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALB—ulcerative colitis	5.3e-06	2.07e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	4.64e-06	1.81e-05	CbGpPWpGaD
